SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 32, Issue 5, 2014, Pages 373-375

Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma

(2) Krell, Jonathan a Stebbing, Justin a

a IMPERIAL COLLEGE LONDON (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IPILIMUMAB; PACLITAXEL; RECOMBINANT ALPHA INTERFERON; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT CHEMOTHERAPY; ALGORITHM; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL (TOPIC); COLON CANCER; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; EDITORIAL; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPROMISED PATIENT; KAPOSI SARCOMA; LYMPHOCYTE COUNT; LYMPHOMA; MELANOMA; NEUTROPENIA; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PATIENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; SOUTH AFRICA; TESTIS CANCER; TUMOR VOLUME; VIRUS LOAD; AIDS RELATED COMPLEX; FEMALE; MALE; NOTE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTHRACYCLINES; ANTI-HIV AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; FEMALE; HUMANS; MALE; SARCOMA, KAPOSI;

EID: 84897576509 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2013.53.7126 Document Type: Editorial

Times cited : (12)

References (16)

1
- 0041627379
- A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
- DOI 10.1097/00002030-200307250-00001
- Portsmouth S, Stebbing J, Gill J, et al: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17:F17-22, 2003 (Pubitemid 36951678)
- (2003) AIDS , vol.17 , Issue.11
- Portsmouth, S.¹ Stebbing, J.² Gill, J.³ Mandalia, S.⁴ Bower, M.⁵ Nelson, M.⁶ Gazzard, B.⁷

2
- 0037211556
- Reduced incidence of kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy [1]
- DOI 10.1002/ijc.10790
- Carrieri MP, Pradier C, Piselli P, et al: Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103:142-144, 2003 (Pubitemid 35424220)
- (2003) International Journal of Cancer , vol.103 , Issue.1 , pp. 142-144
- Carrieri, M.P.¹ Pradier, C.² Piselli, P.³ Piche, M.⁴ Rosenthal, E.⁵ Heudier, P.⁶ Durant, J.⁷ Serraino, D.⁸

3
- 0030765515
- Aids-related Kaposi's sarcoma: Prospective validation of the AIDS clinical trials group staging classification
- Krown SE, Testa MA, Huang J: AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification - AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 15:3085-3092, 1997 (Pubitemid 27377500)
- (1997) Journal of Clinical Oncology , vol.15 , Issue.9 , pp. 3085-3092
- Krown, S.E.¹ Testa, M.A.² Huang, J.³

4
- 0024432019
- Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
- Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria - AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7:1201-1207, 1989 (Pubitemid 19220121)
- (1989) Journal of Clinical Oncology , vol.7 , Issue.9 , pp. 1201-1207
- Krown, S.E.¹ Metroka, C.² Wernz, J.C.³

5
- 33646172829
- A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy
- Stebbing J, Sanitt A, Nelson M, et al: A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet 367:1495-1502, 2006
- (2006) Lancet , vol.367 , pp. 1495-1502
- Stebbing, J.¹ Sanitt, A.² Nelson, M.³

6
- 0037140112
- Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma
- DOI 10.1002/ijc.10274
- Tam HK, Zhang ZF, Jacobson LP, et al: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916-922, 2002 (Pubitemid 34286691)
- (2002) International Journal of Cancer , vol.98 , Issue.6 , pp. 916-922
- Tam, H.K.¹ Zhang, Z.-F.² Jacobson, L.P.³ Margolick, J.B.⁴ Chmiel, J.S.⁵ Rinaldo, C.⁶ Detels, R.⁷

7
- 2342455103
- Where does HIV live?
- Stebbing J, Gazzard B, Douek DC: Where does HIV live? N Engl J Med 350:1872-1880, 2004
- (2004) N Engl J Med , vol.350 , pp. 1872-1880
- Stebbing, J.¹ Gazzard, B.² Douek, D.C.³

8
- 0035423963
- + T lymphocytes in HIV-infected individuals following antiretroviral therapy
- DOI 10.1016/S0952-7915(00)00245-4
- Carcelain G, Debré P, Autran B: Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol 13:483-488, 2001 (Pubitemid 32728483)
- (2001) Current Opinion in Immunology , vol.13 , Issue.4 , pp. 483-488
- Carcelain, G.¹ Debre, P.² Autran, B.³

9
- 24644432549
- Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma
- DOI 10.1200/JCO.2005.14.597
- Bower M, Nelson M, Young AM, et al: Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23:5224-5228, 2005 (Pubitemid 46224033)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.22 , pp. 5224-5228
- Bower, M.¹ Nelson, M.² Young, A.M.³ Thirlwell, C.⁴ Newsom-Davis, T.⁵ Mandalia, S.⁶ Dhillon, T.⁷ Holmes, P.⁸ Gazzard, B.G.⁹ Stebbing, J.¹⁰

10
- 0023613647
- Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome
- Gelmann EP, Longo D, Lane HC, et al: Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am J Med 82:456-462, 1987
- (1987) Am J Med , vol.82 , pp. 456-462
- Gelmann, E.P.¹ Longo, D.² Lane, H.C.³

11
- 15844421721
- Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma
- DOI 10.1002/(SICI)1097-0142(19960515)77:10<2117::A
- Tavio M, Vaccher E, Antinori A, et al: Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma. Cancer 77:2117-2122, 1996 (Pubitemid 26142058)
- (1996) Cancer , vol.77 , Issue.10 , pp. 2117-2122
- Tavio, M.¹ Vaccher, E.² Antinori, A.³ Ammassari, A.⁴ Cusini, M.⁵ Fasan, M.⁶ Accurso, V.⁷ Garavelli, L.P.⁸ Repetto, L.⁹ Tirelli, U.¹⁰

12
- 0031861021
- Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
- Northfelt DW, Dezube BJ, Thommes JA, et al: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J Clin Oncol 16:2445-2451, 1998 (Pubitemid 28309039)
- (1998) Journal of Clinical Oncology , vol.16 , Issue.7 , pp. 2445-2451
- Northfelt, D.W.¹ Dezube, B.J.² Thommes, J.A.³ Miller, B.J.⁴ Fischl, M.A.⁵ Friedman-Kien, A.⁶ Kaplan, L.D.⁷ Du, M.C.⁸ Mamelok, R.D.⁹ Henry, D.H.¹⁰

13
- 77956861383
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: Evidence of symptom palliation from chemotherapy
- Cianfrocca M, Lee S, Von Roenn J, et al: Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: Evidence of symptom palliation from chemotherapy. Cancer 116:3969-3977, 2010
- (2010) Cancer , vol.116 , pp. 3969-3977
- Cianfrocca, M.¹ Lee, S.² Von Roenn, J.³

14
- 10744225451
- Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlations
- DOI 10.1093/annonc/mdg461
- Stebbing J, Wildfire A, Portsmouth S, et al: Paclitaxel for anthracyclineresistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlations. Ann Oncol 14:1660-1666, 2003 (Pubitemid 37455816)
- (2003) Annals of Oncology , vol.14 , Issue.11 , pp. 1660-1666
- Stebbing, J.¹ Wildfire, A.² Portsmouth, S.³ Powles, T.⁴ Thirlwell, C.⁵ Hewitt, P.⁶ Nelson, M.⁷ Patterson, S.⁸ Mandalia, S.⁹ Gotch, F.¹⁰ Gazzard, B.G.¹¹ Bower, M.¹²

15
- 7244248657
- Protease inhibitors potentiate chemotherapy-induced neutropenia
- DOI 10.1182/blood-2004-05-1747
- Bower M, McCall-Peat N, Ryan N, et al: Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood 104:2943-2946, 2004 (Pubitemid 39434985)
- (2004) Blood , vol.104 , Issue.9 , pp. 2943-2946
- Bower, M.¹ McCall-Peat, N.² Ryan, N.³ Davies, L.⁴ Young, A.M.⁵ Gupta, S.⁶ Nelson, M.⁷ Gazzard, B.⁸ Stebbing, J.⁹

16
- 84862119923
- A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa
- Mosam A, Shaik F, Uldrick TS, et al: A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr 60:150-157, 2012
- (2012) J Acquir Immune Defic Syndr , vol.60 , pp. 150-157
- Mosam, A.¹ Shaik, F.² Uldrick, T.S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.